My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
March 2009
Vol. 19 No. 3
Your Colleagues
Welcome New IDSA Members!

Members

Akhtar, Kamran, MD
Calistru, Petre Iacob, MD, PhD
Fernandes, Prabhavathi, PhD
Oberhelman, Richard, MD
Rice, Charles, PhD
Rodriguez, Lourdes, MD

Associate

Casanova, Jean-Laurent, MD, PhD
Davenport, Stacey, MBA, PhD
Halsey, Jennifer, PharmD
Hopkins, Heidi, MD
McCarthy, Paul, MD
Mielle, Amaury, MD
Nagvekar, Vasant, MD
Ng, Wing Kee
Posluszny, Robert, BCh, MS, MSc
Samir-Moez, Hazem, MD
Seiter, Karen, MD
Soyemi, Kenneth, MD
Tamin, Kristen, RPh
Wahawisan, Joy, PharmD
Yongabi, Kenneth, MSc

Members-In-Training

Abuelo, Carolina, MD, DTM&H
Armstrong, Catharina, MD
Bark, Charles, MD
Barnabas, Ruanne, BCh, MB, PhD
Jinno, Sadao, MD
Mejia, Rojelio, MD
Murphy, Richard, MD
Muzaffer, Riffat, MD
Patel, Toral, MD
Patterson, Jennifer, DO
Ramsetty, Sabena, MD

< Previous Article |

Post a comment

Your name:

Your comment:


Top Stories
New Influenza Guidelines Released
CDC Calls for Stepped-up Efforts against Carbapenem-resistant Bugs
Long-awaited FDA Guidance on CAP Drugs Released
IDSA Journal Club
Patient Care and Science
EIN: Better Testing for C. difficile
Drug Approvals, Recalls, Adverse Events Update
Practice Management
Medical Societies Raise Concerns About Medicare Audit Program
Global ID
New HIV/TB Figures Call for Increased Funding, ID Center Says
Policy and Advocacy
IDSA Responds to Supermarketsí Free Antibiotics Promotions
Forum Makes the Case for Medicare Coverage of Home Infusion Therapy
Deadline Extended for Public Input on Lyme Disease Guidelines
Your Colleagues
Welcome New IDSA Members!

IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'idsa@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.